The F. Edward Hébert School of Medicine

Medicine & Life Sciences

1. Wounds and Injuries 100%
2. Military Personnel 51%
3. HIV 48%
4. HIV-1 43%
5. Military Health Services 41%
6. Vaccines 40%
7. Infections 40%
8. Neoplasms 39%
9. Therapeutics 38%
10. Prostatic Neoplasms 33%
11. Population 29%
12. Traumatic Brain Injury 25%
13. Afghanistan 24%
14. Breast Neoplasms 24%
15. Mortality 23%
16. Coronavirus 23%
17. Confidence Intervals 23%
18. T-Lymphocytes 22%
19. Cohort Studies 22%
20. Extremities 22%
21. Biomarkers 22%
22. Survival 21%
23. Iraq 21%
24. Proteins 21%
25. Health 20%
26. Genes 20%
27. Antibodies 20%
28. Vaccination 20%
29. Pandemics 19%
30. Incidence 19%
31. Transplants 19%
32. Resuscitation 18%
33. Amputation 18%
34. Delivery of Health Care 18%
35. Swine 18%
36. Systematic Reviews 18%
37. Diarrhea 18%
38. Proteomics 17%
39. Surgeons 17%
40. Malaria 17%
41. HIV Infections 17%
42. Odds Ratio 17%
43. Lower Extremity 17%
44. Heterotopic Ossification 16%
45. Serum 16%
46. Hemorrhagic Shock 16%
47. SARS Virus 16%
48. Physicians 16%
49. Armed Conflicts 15%
50. Guidelines 15%
51. Epidemiology 15%
52. Education 15%
53. Sepsis 15%
54. Safety 14%
55. Inflammation 14%
56. Nitric Oxide 14%
57. Critical Care 14%
58. Hemorrhage 14%
59. Post-Traumatic Stress Disorders 13%
60. Kidney 13%
61. Anti-Bacterial Agents 13%
62. Skin 13%
63. Medicine 13%
64. Blood Vessels 13%
65. Liver 13%
66. Communicable Diseases 12%
67. Genome 12%
68. Lung 12%
69. Veterans 12%
70. Pharmaceutical Preparations 12%
71. Virus Diseases 12%
72. Allografts 12%
73. AIDS Vaccines 12%
74. Balloon Occlusion 12%
75. Viruses 12%
76. Hospital Emergency Service 11%
77. Clinical Trials 11%
78. Child 11%
79. Antibody Formation 11%
80. Disease Outbreaks 11%
81. Primates 11%
82. Registries 11%
83. Equipment and Supplies 11%
84. Antigens 11%
85. Extracellular Matrix 11%
86. Dengue Virus 11%
87. Gene Expression 10%
88. Demography 10%
89. Cytokines 10%
90. Muscles 10%
91. Military Facilities 10%
92. Prospective Studies 10%
93. In Vitro Techniques 10%
94. Costs and Cost Analysis 10%
95. Morbidity 10%
96. Randomized Controlled Trials 10%
97. Pain 10%
98. B-Lymphocytes 10%
99. Students 10%
100. Growth 10%